TACR1: A Potential Drug Target and Neurokinin Receptor in Tachykinin NK1

Target Name: TACR1

NCBI ID: G6869

TACR1

TACR1: A Potential Drug Target and Neurokinin Receptor in Tachykinin NK1

Abstract:

Tachykinin NK1 (Neurokinin) receptor is a G protein-coupled receptor (GPCR) that plays a crucial role in neural circuits, particularly in the modulation of pain modulation and anxiety. TACR1, the catalytic subunit of the Tachykinin NK1 receptor, has been identified as a potential drug target in the treatment of chronic pain and anxiety disorders. This article summarizes the current understanding of TACR1, its function in neural circuits, and its potential as a drug target.

Introduction:

Tachykinin NK1 (Neurokinin) receptor is a GPCR that is expressed in various tissues, including brain, pancreas, and skeletal muscles. The Tachykinin NK1 receptor is involved in the modulation of pain modulation and anxiety, and its function is crucial in the regulation of neural circuits.

TACR1, the catalytic subunit of the Tachykinin NK1 receptor, is a GPCR that is characterized by its unique catalytic mechanism, which involves a suicide-inducing conformational change of the receptor. This mechanism allows TACR1 to function as an allosteric modulator, which means that it can modulate the activity of other GPCRs by interacting with their extracellular loops.

Despite the importance of TACR1 in neural circuits, its function and regulation are not well understood. The identification of TACR1 as a potential drug target has significant implications for the development of new treatments for chronic pain and anxiety disorders.

Current Understanding of TACR1:

TACR1 is a 21-kDa protein that is expressed in various tissues, including brain, pancreas, and skeletal muscles. The TACR1 receptor is involved in the modulation of pain modulation and anxiety, and its function is crucial in the regulation of neural circuits.

Recent studies have provided new insights into the regulation of TACR1. It has been shown that TACR1 is involved in the modulation of pain sensitivity, with increased TACR1 expression and activity in response to pain stimuli leading to increased pain perception. Additionally, TACR1 has been shown to be involved in the regulation of anxiety, with increased TACR1 expression and activity in response to anxiety stimuli leading to increased anxiety behavior.

In addition to its role in pain and anxiety regulation, TACR1 is also involved in the modulation of neural circuits, with increased TACR1 expression and activity in response to sensory stimuli. This suggests that TACR1 plays an important role in the regulation of neural circuits and their function in the regulation of pain and anxiety.

Potential Drug Target:

The identification of TACR1 as a potential drug target has significant implications for the development of new treatments for chronic pain and anxiety disorders. The function of TACR1 as a pain and anxiety modulator suggests that targeting TACR1 may be an effective way to treat these disorders.

Current research is focused on the development of small molecule inhibitors of TACR1 that can modulate its activity and function. These inhibitors are being tested for their potential therapeutic effects in the treatment of chronic pain and anxiety disorders.

Conclusion:

Tachykinin NK1 (Neurokinin) receptor is a crucial component of neural circuits and plays a crucial role in the regulation of pain modulation and anxiety. The identification of TACR1 as a potential drug target has significant implications for the development of new treatments for chronic pain and anxiety disorders. Further research is needed to understand the full function of TACR1 and the development of effective inhibitors of its activity.

Protein Name: Tachykinin Receptor 1

Functions: This is a receptor for the tachykinin neuropeptide substance P. It is probably associated with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinity of this receptor to tachykinins is: substance P > substance K > neuromedin-K

The "TACR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TACR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets